Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Ginkgo Bioworks Holdings Inc’s current trading price is -83.67% away from its 52-week high, while its distance from the 52-week low is 47.60%. The stock’s price range over this period has fluctuated between $5.00 and $45.20. The company, operating within the financial sector, had a trading volume of approximately 0.83 million for the day, which was noticeably lower than the average daily share volume of 1.69 million over the last 3 months.
Ginkgo Bioworks Holdings Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $45.20 on 05/06/24, while the lowest price for the same period was registered at $5.00 on 04/04/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly decline of -39.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 428.29M and boasts a workforce of 834 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.53, with a change in price of -2.23. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,593,389 in trading volume during the last 100 days, posting a change of -23.20%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.65. Similarly, the long-term debt-to-equity ratio is also 0.61.
DNA Stock Stochastic Average
Today, Ginkgo Bioworks Holdings Inc’s raw stochastic average for the past 50 days stands at 21.72%, indicating a decline from the raw stochastic average of the last 20 days, which was 64.50%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 74.44% and 76.12% respectively.
DNA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -24.85% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -7.05%. Over the past 30 days, the price of DNA has fallen by 20.59%. And in the last five days, it has fallen by -2.12%.
